CIP
GILD icon

Champlain Investment Partners’s Gilead Sciences GILD Stock Holding History

Champlain Investment Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-4,000
Closed -$316K – 130
2016
Q3 		$316K Buy
+4,000
New +$325K ﹤0.01% 128

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Champlain Investment Partners's GILD Position: Q4 2016 in Review

Champlain Investment Partners sold out of Gilead Sciences (GILD) in Q4 2016, closing a stake of 4,000 shares — an estimated $316K sold.

Champlain Investment Partners first reported a position in GILD in Q3 2016 and held it in 1 quarter. The position peaked at $316K in Q3 2016. 1,573 funds tracked by Wall St. Rank hold GILD as of Q4 2016.

  • Champlain Investment Partners reported no remaining Gilead Sciences position as of Q4 2016 after selling out during the quarter.
  • Champlain Investment Partners sold 4,000 Gilead Sciences shares in Q4 2016, an estimated $316K.
  • Champlain Investment Partners first reported a position in Gilead Sciences in Q3 2016 and held it in 1 quarter.
  • Champlain Investment Partners's Gilead Sciences position peaked at $316K in Q3 2016.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2016.

Based on Champlain Investment Partners's 13F filing for Q4 2016, filed 13 Feb 2017.